全文获取类型
| 收费全文 | 29337篇 |
| 免费 | 2724篇 |
| 国内免费 | 843篇 |
专业分类
| 耳鼻咽喉 | 52篇 |
| 儿科学 | 582篇 |
| 妇产科学 | 174篇 |
| 基础医学 | 2311篇 |
| 口腔科学 | 310篇 |
| 临床医学 | 5091篇 |
| 内科学 | 10622篇 |
| 皮肤病学 | 60篇 |
| 神经病学 | 543篇 |
| 特种医学 | 1321篇 |
| 外国民族医学 | 1篇 |
| 外科学 | 3600篇 |
| 综合类 | 4039篇 |
| 现状与发展 | 2篇 |
| 预防医学 | 554篇 |
| 眼科学 | 63篇 |
| 药学 | 2262篇 |
| 24篇 | |
| 中国医学 | 914篇 |
| 肿瘤学 | 379篇 |
出版年
| 2024年 | 19篇 |
| 2023年 | 586篇 |
| 2022年 | 681篇 |
| 2021年 | 1239篇 |
| 2020年 | 1453篇 |
| 2019年 | 1403篇 |
| 2018年 | 1304篇 |
| 2017年 | 1057篇 |
| 2016年 | 966篇 |
| 2015年 | 1126篇 |
| 2014年 | 1991篇 |
| 2013年 | 2217篇 |
| 2012年 | 1493篇 |
| 2011年 | 1708篇 |
| 2010年 | 1323篇 |
| 2009年 | 1360篇 |
| 2008年 | 1389篇 |
| 2007年 | 1397篇 |
| 2006年 | 1278篇 |
| 2005年 | 1153篇 |
| 2004年 | 911篇 |
| 2003年 | 790篇 |
| 2002年 | 644篇 |
| 2001年 | 607篇 |
| 2000年 | 403篇 |
| 1999年 | 467篇 |
| 1998年 | 374篇 |
| 1997年 | 379篇 |
| 1996年 | 281篇 |
| 1995年 | 315篇 |
| 1994年 | 300篇 |
| 1993年 | 246篇 |
| 1992年 | 235篇 |
| 1991年 | 236篇 |
| 1990年 | 192篇 |
| 1989年 | 134篇 |
| 1988年 | 144篇 |
| 1987年 | 135篇 |
| 1986年 | 117篇 |
| 1985年 | 159篇 |
| 1984年 | 143篇 |
| 1983年 | 102篇 |
| 1982年 | 70篇 |
| 1981年 | 94篇 |
| 1980年 | 70篇 |
| 1979年 | 46篇 |
| 1978年 | 43篇 |
| 1977年 | 41篇 |
| 1976年 | 30篇 |
| 1975年 | 18篇 |
排序方式： 共有10000条查询结果，搜索用时 62 毫秒
51.
J.P. Darche Megan J. Murray Kristina M. Bridges Joe Noland K. Allen Greiner 《Journal of Science and Medicine in Sport》2019,22(4):484-487
Objectives
Professional athletes undergo annual pre-season laboratory screening, although clinical evidence supporting the practice is limited and no uniform set of guidelines on pre-season laboratory screening exists. The aim of this study was to assess the clinical value of annual pre-season laboratory screening tests for a major professional sports team over multiple years.Design
Retrospective chart review.Methods
A retrospective analysis was performed of all laboratory results as well as screening ECGs for a single major professional sports team over a 9-year timeframe (2009–2017).Results
The data show that 10.01% of initial screening test results were abnormal and 40.32% of abnormal tests resulted in additional testing. Overall, only 0.35% of initial tests resulted in a clinically significant outcome. Non-US born players showed a significantly higher average rate of abnormal tests/year compared to US-born players (p-value 0.006), but there was no difference in clinically significant outcomes. There was no relationship between athlete age and laboratory screening outcomes.Conclusions
In our study population, yearly pre-season laboratory screening of professional athletes did not yield substantial clinically significant outcomes and would not be warranted under normal clinical standards. Future best practice guidelines should combine research concerning effects of family medical history, race, gender, country of origin, and type of sport on athlete health when creating recommendations for which pre-season laboratory screenings may be pertinent even with evidence of little utility. 相似文献52.
53.
54.
目的研究芪苈强心胶囊联合托伐普坦片治疗中度充血性心力衰竭的临床效果。方法选取2017年1月—2018年1月安阳地区医院收治的中度充血性心力衰竭患者80例为研究对象,采用随机数字表法随机分为对照组和治疗组,每组各40例。对照组口服托伐普坦片,起始剂量为15mg,服药24h后,根据血清钠浓度调整剂量,最大用药剂量为60mg,当血钠浓度145 mmol/L时停用。治疗组在对照组治疗的基础上温水口服芪苈强心胶囊,4粒/次,3次/d。两组患者均连续服用7d。观察两组的临床疗效,比较两组的血清Na~+、K~+浓度、体质量、心功能和炎性因子水平。结果治疗后,对照组和治疗组的总有效率分别为75.00%、92.50%,两组比较差异有统计学意义(P0.05)。治疗后,两组Na+浓度显著提高,而体质量显著减轻,同组治疗前后比较差异有统计学意义(P0.05);且治疗后治疗组体质量显著低于对照组,两组比较差异有统计学意义(P0.05)。治疗后,两组每搏量(SV)、心排血量(CO)和左心室射血分数(LVEF)值均显著升高,同组治疗前后比较差异有统计学意义(P0.05);且治疗后治疗组心功能指标水平均显著高于对照组,两组比较差异有统计学意义(P0.05)。治疗后,两组血浆一氧化氮(NO)和血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平均显著降低,同组治疗前后比较差异有统计学意义(P0.05);且治疗后治疗组各炎性因子水平显著低于对照组,两组比较差异有统计学意义(P0.05)。结论芪苈强心胶囊联合托伐普坦片治疗中度充血性心力衰竭具有较好的临床疗效,能调节机体电解质平衡,改善心功能,安全性较好,具有一定的临床推广应用价值。 相似文献
55.
Ewelina Kazimierczyk Andrzej Eljaszewicz Paula Zembko Ewa Tarasiuk Malgorzata Rusak Agnieszka Kulczynska-Przybik Marta Lukaszewicz-Zajac Karol Kaminski Barbara Mroczko Maciej Szmitkowski Milena Dabrowska Bozena Sobkowicz Marcin Moniuszko Agnieszka Tycinska 《Pharmacological reports : PR》2019,71(1):73-81
Background
Acute myocardial infarction (AMI) causes irreversible myocardial damage and release of inflammatory mediators, including cytokines, chemokines and miRNAs. We aimed to investigate changes in the levels of cytokines (IL-6, TNF-α and IL-10), miRNAs profiles (miR-146 and miR-155) and distribution of different monocyte subsets (CD14++CD16-, CD14++CD16+, CD14+CD16++) in the acute and post-healing phases of AMI.Methods
In eighteen consecutive AMI patients (mean age 56.78?±?12.4 years, mean left ventricle ejection fraction – LVEF: 41.9?±?9.8%), treated invasively, monocyte subsets frequencies were evaluated (flow cytometry), cytokine concentrations were analyzed (ELISA) as well as plasma miRNAs were isolated twice – on admission and after 19.2?±?5.9 weeks of follow-up. Measurements were also performed among healthy volunteers.Results
AMI patients presented significantly decreased frequencies of classical cells in comparison to healthy controls (median 71.22% [IQR: 64.4–79.04] vs. 84.35% [IQR: 81.2–86.7], p?=?0.001) and higher percent of both intermediate and non-classical cells, yet without statistical significance (median 6.54% [IQR: 5.14–16.64] vs. 5.87% [IQR: 4.48–8.6], p?=?0.37 and median 5.99% [IQR: 3.39–11.5] vs. 5.26% [IQR: 3.62–6.2], p?=?0.42, respectively). In AMI patients both, analyzed plasma miRNA concentrations were higher than in healthy subjects (miR-146: median 5.48 [IQR: 2.4–11.27] vs. 1.84 [IQR: 0.87–2.53], p?=?0.003; miR-155: median 25.35 [IQR: 8.17–43.15] vs. 8.4 [IQR: 0.08–16.9], p?=?0.027, respectively), and returned back to the values found in the control group in follow-up. miR-155/miR-146 ratio correlated with the frequencies of classical monocytes (r=0.6, p?=?0.01) and miR-155 correlated positively with the concentration of inflammatory cytokines ? IL-6 and TNF-α.Conclusions
These results may suggest cooperation of both pro-inflammatory and anti-inflammatory signals in AMI in order to promote appropriate healing of the infarcted myocardium. 相似文献56.
杜纪鸣老师认为,冠状动脉粥样硬化性心脏病(简称冠心病)的发生、发展,与多种因素紧密相关,其常见发病原因有寒邪内侵、饮食不节、情志失调、体虚劳倦等,与人体的代谢及生理功能失调关系紧密。心脉痹阻为本病主要病机,一方面因虚致实,另一方面因实致虚。气虚、血瘀两种病理产物贯穿本病始终。临证时,杜老师遵循益气活血、化瘀通脉止痛治疗大法,把辨脏腑、辨主症、辨兼症等辨证方法融汇其中,同时不忘借鉴现代中药药理学研究成果完善方药。杜老师提出,对有易感因素的中青年易患人群,一定要早预防,通过早期调补脾肾、调理内分泌、代谢紊乱等,能有效预防疾病的发生,延缓疾病的发展等。 相似文献
57.
58.
59.
60.